Devon P. Ryan, Ph.D. - Related publications

Affiliations: 
2010-2015 DZNE, München, Bayern, Germany 
 2015- MPI for Immunobiology and Epigenetics 
Area:
Bioinformatics, neuronal alterations associated with neurocognitive and neurodegenerative disorders
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
3 most relevant papers in past 60 days:
Year Citation  Score
2020 Noor NM, Verstockt B, Parkes M, Lee JC. Personalised medicine in Crohn's disease. The Lancet. Gastroenterology & Hepatology. 5: 80-92. PMID 31818474 DOI: 10.1016/S2468-1253(19)30340-1   
2020 Chen Y, Chen Y, Liang Y, Chen H, Ji X, Huang M. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 121: 109670. PMID 31810131 DOI: 10.1016/j.biopha.2019.109670   
2020 Zhang S, Zhang J, Wei D, An H, Liu W, Lai Y, Yang T, Shao W, Huang Y, Wang L, Dou F, Peng D, Zhang Z. Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 121: 109682. PMID 31810113 DOI: 10.1016/j.biopha.2019.109682